NEWS 01.07.2026 Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue – The Globe and Mail
NEWS 01.07.2026 Creative Medical’s BioDefense initiative receives regulatory approval By Investing.com – Investing.com India
NEWS 01.07.2026 Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction Repair: Therapeutic Potential and Scaffold-based Delivery Strategies – Frontiers
NEWS 01.07.2026 Texas A&M researchers uncover new insights into bone healing challenges for people with Down syndrome – Texas A&M Stories
